Tuberculosis: a problem with persistence - PubMed (original) (raw)
Review
Tuberculosis: a problem with persistence
Graham R Stewart et al. Nat Rev Microbiol. 2003 Nov.
Abstract
Mycobacterium tuberculosis is one of most successful pathogens of mankind, infecting one-third of the global population and claiming two million lives every year. The ability of the bacteria to persist in the form of a long-term asymptomatic infection, referred to as latent tuberculosis, is central to the biology of the disease. The persistence of bacteria in superficially normal tissue was recognized soon after the discovery of the tubercle bacillus, and much of our knowledge about persistent populations of M. tuberculosis dates back to the first half of the last century. Recent advances in microbial genetics and host immunity provide an opportunity for renewed investigation of this persistent threat to human health.
Similar articles
- Animal models of M. tuberculosis Infection.
Orme I, Gonzalez-Juarrero M. Orme I, et al. Curr Protoc Microbiol. 2007 Nov;Chapter 10:Unit 10A.5. doi: 10.1002/9780471729259.mc10a05s7. Curr Protoc Microbiol. 2007. PMID: 18770606 - Pathogenesis of tuberculosis: pathway to apical localization.
Balasubramanian V, Wiegeshaus EH, Taylor BT, Smith DW. Balasubramanian V, et al. Tuber Lung Dis. 1994 Jun;75(3):168-78. doi: 10.1016/0962-8479(94)90002-7. Tuber Lung Dis. 1994. PMID: 7919306 Review. - B7 costimulation is critical for host control of chronic Mycobacterium tuberculosis infection.
Bhatt K, Uzelac A, Mathur S, McBride A, Potian J, Salgame P. Bhatt K, et al. J Immunol. 2009 Mar 15;182(6):3793-800. doi: 10.4049/jimmunol.0802996. J Immunol. 2009. PMID: 19265158 - The American cotton rat: a novel model for pulmonary tuberculosis.
Elwood RL, Wilson S, Blanco JC, Yim K, Pletneva L, Nikonenko B, Samala R, Joshi S, Hemming VG, Trucksis M. Elwood RL, et al. Tuberculosis (Edinb). 2007 Mar;87(2):145-54. doi: 10.1016/j.tube.2006.07.001. Epub 2006 Sep 12. Tuberculosis (Edinb). 2007. PMID: 16973421 - Experimental models used to study human tuberculosis.
O'Toole R. O'Toole R. Adv Appl Microbiol. 2010;71:75-89. doi: 10.1016/S0065-2164(10)71003-0. Epub 2010 Feb 20. Adv Appl Microbiol. 2010. PMID: 20378051 Review.
Cited by
- Therapeutic Potential of Resveratrol and Lignans in the Management of Tuberculosis.
Jubilee R, Komala M, Patel S. Jubilee R, et al. Cell Biochem Biophys. 2024 Sep;82(3):1809-1823. doi: 10.1007/s12013-024-01378-7. Epub 2024 Jun 24. Cell Biochem Biophys. 2024. PMID: 38914838 Review. - Drug-Tolerant Mycobacterium tuberculosis Adopt Different Survival Strategies in Alveolar Macrophages of Patients with Pulmonary Tuberculosis.
Ufimtseva EG, Eremeeva NI. Ufimtseva EG, et al. Int J Mol Sci. 2023 Oct 6;24(19):14942. doi: 10.3390/ijms241914942. Int J Mol Sci. 2023. PMID: 37834390 Free PMC article. - Impact of Genomic Deletion RD16 on the Expression of the Mycobacterium bovis BCG Moreau VapBC47 Toxin-Antitoxin System.
Pagani TD, Corrêa PR, Lima C, Gomes LHF, Schwarz MGA, Galvão TC, Degrave WM, Valadares NF, Mendonça-Lima L. Pagani TD, et al. Curr Issues Mol Biol. 2023 Aug 7;45(8):6538-6549. doi: 10.3390/cimb45080412. Curr Issues Mol Biol. 2023. PMID: 37623231 Free PMC article. - Toxin-antitoxin systems in bacterial pathogenesis.
Sonika S, Singh S, Mishra S, Verma S. Sonika S, et al. Heliyon. 2023 Mar 3;9(4):e14220. doi: 10.1016/j.heliyon.2023.e14220. eCollection 2023 Apr. Heliyon. 2023. PMID: 37101643 Free PMC article. Review. - Fulminant pulmonary tuberculosis in a previously healthy young woman from the Marshall Islands: Potential risk factors.
Rockstrom M, Lutz R, Dickeson K, O'Rorke EV, Narita M, Amram O, Chan ED. Rockstrom M, et al. J Clin Tuberc Other Mycobact Dis. 2023 Feb 26;31:100351. doi: 10.1016/j.jctube.2023.100351. eCollection 2023 May. J Clin Tuberc Other Mycobact Dis. 2023. PMID: 36923241 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources